Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

56.0K
Overview
56.0K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

60
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
60
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

64
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
64
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

175
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
175
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

288
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
288
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

270
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolving Etiology of Hospital-Acquired and Ventilator-Associated Pneumonia.

Clinics in chest medicine·2026
Same author

Effective spectrum-based antibiotic resistance index for monitoring resistance in Gram-negative bacilli.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Plasma Ceramides Levels in Severe COVID-19 Disease: Correlations with Survival.

Open forum infectious diseases·2026
Same author

Optimal Spectrum Antibiotic Ratio for assessing antibiotic utilisation in sepsis caused by gram-negative bacilli.

EBioMedicine·2026
Same author

Optimal antibiotic use in the intensive care unit.

Critical care (London, England)·2025
Same author

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial.

Therapeutic advances in infectious disease·2025

Related Experiment Video

Updated: Oct 3, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Antibiotic Decision-Making in the ICU.

Luis Parra-Rodriguez1, M Cristina Vazquez Guillamet1,2

  • 1Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Seminars in Respiratory and Critical Care Medicine
|February 16, 2022
PubMed
Summary

Optimizing antibiotic use in Intensive Care Units (ICUs) is crucial for patient outcomes. This review guides intensivists on when to start, what spectrum to choose, and when to de-escalate antibiotic therapy.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.6K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.9K

Related Experiment Videos

Last Updated: Oct 3, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

26.6K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.9K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Intensive Care Units (ICUs) are major centers for antimicrobial consumption, significantly impacting antibiotic resistance.
  • Infections in critically ill patients, including septic shock, present complex treatment challenges for intensivists.
  • Inappropriate antibiotic use (under- or over-treatment) can lead to adverse patient outcomes.

Purpose of the Study:

  • To review evidence guiding antibiotic decision-making in the ICU.
  • To address the critical choices of initiating antibiotics, selecting empiric spectrum, and de-escalating therapy.
  • To explore the potential of machine learning and artificial intelligence in optimizing antimicrobial selection.

Main Methods:

  • Review of existing evidence on antibiotic use in ICUs.
  • Focus on the three key decision points in antibiotic therapy: initiation, empiric selection, and de-escalation.
  • Discussion of the role of advanced computational models for clinical decision support.

Main Results:

  • Antibiotic decision-making in ICUs involves complex factors, including infection risk and pathogen prevalence.
  • Rapid diagnostics aid, but a window for empiric decisions with limited data remains.
  • Continuous ICU data streams offer opportunities for sophisticated antimicrobial optimization models.

Conclusions:

  • Effective antibiotic stewardship in the ICU requires careful consideration of initiation, spectrum, and de-escalation.
  • Machine learning and AI hold promise for developing clinical decision support systems to improve antibiotic selection.
  • Optimized antibiotic strategies can enhance patient outcomes in ICUs and mitigate ecological consequences.